Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Brain Neoplasms × ruxolitinib × Clear all

Sponsor

Conditions

Primary Myelofibrosis 15 Myeloproliferative Disorders 13 Polycythemia Vera 8 Breast Neoplasms 6 Leukemia, Myeloid, Acute 5 Leukemia 5 Pancreatic Neoplasms 4 Multiple Myeloma 4 Hematologic Diseases 4 Myelodysplastic Syndromes 3 Bone Marrow Diseases 3 Thrombocytosis 2 Thrombocythemia, Essential 2 Prostatic Neoplasms 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Myelodysplastic-Myeloproliferative Diseases 2 Lymphoma, Follicular 2 Lymphoma 2 Leukemia, Myelomonocytic, Chronic 2 Graft vs Host Disease 2 Carcinoma, Non-Small-Cell Lung 2 Triple Negative Breast Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Pathologic Complete Response 1 Ovarian Neoplasms 1 Neoplasms, Plasma Cell 1 Lymphoproliferative Disorders 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Large B-Cell, Diffuse 1 Leukemia-Lymphoma, Adult T-Cell 1

Interventions

Temozolomide 50 Bevacizumab 42 Radiotherapy 28 Radiosurgery 18 Carboplatin 14 Erlotinib Hydrochloride 10 Radiation 9 pembrolizumab 8 Vorinostat 8 Magnetic Resonance Spectroscopy 8 Irinotecan 8 Trastuzumab 7 Radiotherapy, Intensity-Modulated 7 Etoposide 7 Capecitabine 7 Lomustine 6 Lapatinib 6 dabrafenib 5 Sunitinib 5 Sorafenib 5 Ipilimumab 5 Imatinib Mesylate 5 Everolimus 5 Cyclophosphamide 5 cabozantinib 4 binimetinib 4 Therapeutics 4 Radiotherapy, Conformal 4 NVP-BKM120 4 Immunoglobulin G 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡